Regulus Therapeutics Inc (NASDAQ:RGLS) price closed lower on Tuesday, April 29, and dropping -3.44% below its previous close. A look at the daily price movement shows that the last close reads $3.49, with intraday deals fluctuated between $3.212 and $3.597. The company’s 5Y monthly beta
Regulus Therapeutics Inc (NASDAQ:RGLS) concluded the trading at $2.76 on Friday, April 25 with a fall of -1.43% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.80 and 5Y monthly beta
Regulus Therapeutics Inc (NASDAQ:RGLS) concluded the trading at $2.76 on Friday, April 25 with a fall of -1.43% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.80 and 5Y monthly beta
Regulus Therapeutics Inc (NASDAQ:RGLS) traded at $2.32 at close of the session on Tuesday, April 22 and made an upward move of 15.42% on its previous day’s price. Looking at the stock we see that its previous close was $2.01 and the beta (5Y monthly)
Looking at the stock we see that its previous close was $1.75 and the beta (5Y monthly) reads 1.412 with the day’s price range being $1.67 – $2.05. In terms of its 52-week price range, RGLS has a high of $2.91 and a low of
Regulus Therapeutics Inc (NASDAQ:RGLS) shares, rose in value, with the stock price up by 20.16% to the previous day’s close as strong demand from buyers drove the stock to $1.55. Actively observing the price movement in the recent trading, the stock is buoying the session
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
